アノスミアの世界市場レポート 2025年

アノスミア市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.7％で56億5,000万米ドルに成長します。予測期間の成長は、慢性疾患の有病率の上昇、民間および政府組織からの資金提供の増加、医薬品製造セグメントの開発、医薬品の研究開発活動の増加、アノスミア行為に対する治療薬の増加に起因しています。予測期間における主な動向としては、技術の進歩、アノスミアの高度治療、民間および政府機関からの資金提供の増加、高度な医薬品製造の開発などが挙げられます。

神経疾患の有病率の増加は、今後数年間のアノスミア市場の成長を促進すると予想されます。神経疾患とは、脳、脊髄、末梢神経を含む神経系に影響を及ぼす幅広い疾患を指します。これらの疾患の増加は、主に人口の高齢化と糖尿病や高血圧などの慢性疾患の罹患率の増加によるものです。これらの疾患は、嗅覚経路やにおいを処理する脳の部位を損傷することにより、においを感知・知覚する能力が失われ、アノスミアにつながる可能性があります。例えば、2023年3月、米国の非営利健康団体であるアルツハイマー病協会（Alzheimer's Association）は、65歳以上の米国人が670万人、アルツハイマー型認知症を患っていると報告し、この数は2060年までに1,380万人に達すると予測しています。したがって、神経疾患の発生率の増加がアノスミア市場の拡大に拍車をかけています。

アノスミア市場の主要企業は、嗅覚障害を経験した人に効果的で非侵襲的な治療を提供するため、嗅覚トレーニングキットなどの革新的なソリューションの開発に注力しています。これらのキットは、特にウイルス感染や頭部外傷などの原因によって嗅覚を失ったユーザーの嗅覚の改善や回復を支援するように設計されています。例えば、2022年3月、英国を拠点とするミールキット・プロバイダーであるGousto社は、Flavor Savior嗅覚トレーニング・キットを発表しました。これらのキットは、アノスミアによって嗅覚と味覚を失った人のために、嗅覚受容体を刺激し、これらの感覚の回復を助けることを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界アノスミア PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のアノスミア市場：成長率分析
• 世界のアノスミア市場の実績：規模と成長, 2019-2024
• 世界のアノスミア市場の予測：規模と成長, 2024-2029, 2034F
• 世界アノスミア総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のアノスミア市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 特発性アノスミア
• 先天性アノスミア
• 世界のアノスミア市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 治療法
• 医薬品
• 世界のアノスミア市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• その他のエンドユーザー
• 世界のアノスミア市場特発性嗅覚障害の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 部分的特発性アノスミア
• 完全な特発性アノスミア
• 世界のアノスミア市場先天性嗅覚障害の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 孤立性先天性アノスミア
• 症候群性先天性アノスミア（他の病状または症候群に関連する）

第7章 地域別・国別分析

• 世界のアノスミア市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のアノスミア市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アノスミア市場：競合情勢
• アノスミア市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Sanofi SA
• Bristol-Myers Squibb and Company
• AstraZeneca plc
• Abbott Laboratories
• Novartis AG
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Eli Lily and Company
• Gilead Sciences Inc.
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• Astellas Pharma Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• アノスミア市場2029：新たな機会を提供する国
• アノスミア市場2029：新たな機会を提供するセグメント
• アノスミア市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Anosmia is a medical condition characterized by either a complete or partial loss of the sense of smell. This condition can arise from various factors affecting the olfactory system, such as nasal congestion, nasal polyps, neurological disorders, head injuries, viral infections, or exposure to certain chemicals or medications. Anosmia can be either temporary or permanent and may affect one or both nostrils. It typically diminishes the ability to detect or identify odors, which can impact the sense of taste and overall quality of life.

Anosmia is primarily categorized into idiopathic anosmia and congenital anosmia. Idiopathic anosmia denotes a loss of smell with no identifiable cause, even after extensive medical evaluation and diagnostic testing. Treatments for anosmia may include therapies and medications, with several healthcare providers, including hospitals and clinics, being involved in the management of the condition.

The anosmia market research report is one of a series of new reports from The Business Research Company that provides anosmia market statistics, including the anosmia industry global market size, regional shares, competitors with anosmia market share, detailed anosmia market segments, market trends, and opportunities, and any further data you may need to thrive in the anosmia industry. These anosmia market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The anosmia market size has grown rapidly in recent years. It will grow from $3.55 billion in 2024 to $3.9 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to growing incidence of anosmia cases, increasing number of anosmia cases, rising research grants and research activities for drug development for anosmia, increasing demand for healthcare, and research activities for drug development for anosmia.

The anosmia market size is expected to see strong growth in the next few years. It will grow to $5.65 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising prevalence of chronic diseases, increase in funding from private and government organizations, development of pharmaceutical manufacturing segments, rise in R&D activities for drugs, and rise in therapeutics for anosmia acts. Major trends in the forecast period include technological advancements, advanced treatment for anosmia, increase in funding from private and government organizations, and development of advanced pharmaceutical manufacturing.

The increasing prevalence of neurological disorders is expected to drive the growth of the anosmia market in the coming years. Neurological disorders refer to a wide range of conditions that affect the nervous system, including the brain, spinal cord, and peripheral nerves. The rise in these disorders is primarily due to an aging population and the growing incidence of chronic diseases like diabetes and hypertension. These conditions can lead to anosmia by damaging the olfactory pathways or areas of the brain responsible for processing smells, resulting in the loss of the ability to detect or perceive odors. For example, in March 2023, the Alzheimer's Association, a US-based nonprofit health organization, reported that 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, with projections suggesting this number could reach 13.8 million by 2060. Therefore, the growing incidence of neurological disorders is fueling the expansion of the anosmia market.

Key players in the anosmia market are concentrating on creating innovative solutions, such as smell training kits, to offer effective and non-invasive treatments for individuals experiencing loss of smell. These kits are designed to help users improve or recover their sense of smell, particularly after losing it due to causes such as viral infections or head injuries. For instance, in March 2022, Gousto, a meal kit provider based in the UK, introduced the Flavor Savior smell training kits. These kits aim to help individuals who have lost their sense of smell and taste due to anosmia by stimulating their smell receptors and aiding in the recovery of these senses.

In November 2023, the UK-based charity Fifth Sense collaborated with ENT UK to enhance the care for individuals with smell and taste disorders. This partnership is focused on supporting both patients and healthcare providers dealing with conditions such as anosmia. ENT UK is a professional membership organization representing the field of ear, nose, and throat surgery in the UK.

Major companies operating in the anosmia market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb and Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lily and Company, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Aurobindo Pharma Limited, Cipla Inc., Alphapharm Pty. Ltd., Alde Medi Impex Ltd.

North America was the largest region in the anosmia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the anosmia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anosmia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anosmia market consists of revenues earned by entities by providing services such as olfactory testing and imaging, medical consultations, therapeutic services, medication management, rehabilitative services including psychological support and nutritional counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The anosmia market also includes sales of diagnostic tools, medical devices, and nasal sprays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anosmia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anosmia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anosmia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anosmia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Idiopathic Anosmia; Congenital Anosmia
• 2) By Treatment: Therapies; Medications
• 3) By End User: Hospitals; Clinics; Other End Users
• Subsegments:
• 1) By Idiopathic Anosmia: Partial Idiopathic Anosmia; Complete Idiopathic Anosmia
• 2) By Congenital Anosmia: Isolated Congenital Anosmia; Syndromic Congenital Anosmia (Associated With Other Conditions Or Syndromes)
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anosmia Market Characteristics

3. Anosmia Market Trends And Strategies

4. Anosmia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Anosmia Growth Analysis And Strategic Analysis Framework

• 5.1. Global Anosmia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Anosmia Market Growth Rate Analysis
• 5.4. Global Anosmia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Anosmia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Anosmia Total Addressable Market (TAM)

6. Anosmia Market Segmentation

• 6.1. Global Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Idiopathic Anosmia
• Congenital Anosmia
• 6.2. Global Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapies
• Medications
• 6.3. Global Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End Users
• 6.4. Global Anosmia Market, Sub-Segmentation Of Idiopathic Anosmia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Partial Idiopathic Anosmia
• Complete Idiopathic Anosmia
• 6.5. Global Anosmia Market, Sub-Segmentation Of Congenital Anosmia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Isolated Congenital Anosmia
• Syndromic Congenital Anosmia (Associated With Other Conditions Or Syndromes)

7. Anosmia Market Regional And Country Analysis

• 7.1. Global Anosmia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Anosmia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anosmia Market

• 8.1. Asia-Pacific Anosmia Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anosmia Market

• 9.1. China Anosmia Market Overview
• 9.2. China Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anosmia Market

• 10.1. India Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anosmia Market

• 11.1. Japan Anosmia Market Overview
• 11.2. Japan Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anosmia Market

• 12.1. Australia Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anosmia Market

• 13.1. Indonesia Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anosmia Market

• 14.1. South Korea Anosmia Market Overview
• 14.2. South Korea Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anosmia Market

• 15.1. Western Europe Anosmia Market Overview
• 15.2. Western Europe Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anosmia Market

• 16.1. UK Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anosmia Market

• 17.1. Germany Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anosmia Market

• 18.1. France Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anosmia Market

• 19.1. Italy Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anosmia Market

• 20.1. Spain Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anosmia Market

• 21.1. Eastern Europe Anosmia Market Overview
• 21.2. Eastern Europe Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anosmia Market

• 22.1. Russia Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anosmia Market

• 23.1. North America Anosmia Market Overview
• 23.2. North America Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anosmia Market

• 24.1. USA Anosmia Market Overview
• 24.2. USA Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anosmia Market

• 25.1. Canada Anosmia Market Overview
• 25.2. Canada Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anosmia Market

• 26.1. South America Anosmia Market Overview
• 26.2. South America Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anosmia Market

• 27.1. Brazil Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anosmia Market

• 28.1. Middle East Anosmia Market Overview
• 28.2. Middle East Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anosmia Market

• 29.1. Africa Anosmia Market Overview
• 29.2. Africa Anosmia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Anosmia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Anosmia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anosmia Market Competitive Landscape And Company Profiles

• 30.1. Anosmia Market Competitive Landscape
• 30.2. Anosmia Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Anosmia Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi SA
• 31.3. Bristol-Myers Squibb and Company
• 31.4. AstraZeneca plc
• 31.5. Abbott Laboratories
• 31.6. Novartis AG
• 31.7. GlaxoSmithKline PLC
• 31.8. Takeda Pharmaceutical Company Limited
• 31.9. Eli Lily and Company
• 31.10. Gilead Sciences Inc.
• 31.11. Viatris Inc.
• 31.12. Teva Pharmaceutical Industries Ltd.
• 31.13. Regeneron Pharmaceuticals Inc.
• 31.14. Biogen Inc.
• 31.15. Astellas Pharma Inc.

32. Global Anosmia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anosmia Market

34. Recent Developments In The Anosmia Market

35. Anosmia Market High Potential Countries, Segments and Strategies

• 35.1 Anosmia Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Anosmia Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Anosmia Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer